AllergoOncology WG Symposium: Danger signals, Inflammation in Allergy & Cancer

AllergoOncology WG Symposium: Danger signals, Inflammation in Allergy & Cancer

Talk 1: Keynote lecture – “Danger signals in Allergy and Oncology”

– Welcome – Sophia Karagiannis, King’s College London, Guy’s Hospital, London, UK
– AllergoOncology Working Group update and plans  – Erika Jensen-Jarolim, Medical University Vienna, Vienna, Austria
– Danger signals in Allergy and Oncology – Christoph Bergmann, ENT Research Institute for Clinical Studies, Essen, Germany

Talk 2: Innate Immune response in allergy and cancer – Chaired by Markus Ollert & Erika Jensen-Jarolim

CpG adjuvant in vaccination and immunotherapy: Which lessons have we learned? – Markus Ollert, Department of Infection and Immunity,LIH, Luxembourg
Alterations of the gastrointestinal barrier act as danger signals in allergy and oncology – Eva Untersmayr, Immunologist, University of Vienna, Austria

Talk 3: Mast cells & Granulocytes in allergy and cancer – Chaired by Erika Jensen-Jarolim & Sophia Karagiannis

Eosinphils supressing NK cell anti-tumor potential: Innate immune checkpoints – Martijn Schuijs, PhD, Ghent University, Belgium
Basophils in allergy and beyond – Mariona Pascal, Hospital Clínic, Universitat de Barcelona, Spain
Desensitization to Chemotherapy/biologicals and in vitro models: from the bench to the bedside – Leticia de las Vecillas, University Hospital La Paz, Madrid, Spain

Talk 4: Antigen Presenting Cells – Chaired by Oscar Palomares & Mariona Pascal

Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming – Oscar Palomares, Complutense University of Madrid, Spain
Macrophages/Allergy/Cancer – Elena Izquierdo, PhD, CEU San Pablo University, Madrid, Spain
Don’t stop me now: the intimate relationship between macrophages and antibodies in allergy and cancer – Rodolfo Bianchini, Medical University of Vienna, Austria

Talk 5: Adaptive Immunity – Chaired by Eva Untersmayr & Aurélie Poli

TLRs, T cells, allergen immunotherapy – Mohamed Shamji, Imperial College London,UK
IgE/IgG4 in allergy/cancer – Mübeccel Akdis, University of Zurich, Switzerland
Allergic airway inflammation impacts tumor take and delays experimental glioblastoma progression – Aurélie Poli, Luxembourg Institute of Health, Luxembourg